This being far from my area of expertise, I’d like a reconciliation between this mentality and what others have claimed that all the programming to analyze the data sets has been pre-written once the trial and endpoints have been approved by the FDA leading to quicker analysis. There seems to be a disconnect in expected timelines among our MB experts.

Granted and given that NP hasn’t given too specific of timelines I’m wondering if both are true. The data has been analyzed but then it has to be quadruple checked by hand over the next 3-6 weeks or something along those lines.

As you say, I don’t give a hoot when it comes out as long as it’s done correctly, but it would be helpful to my psyche to have less divergent expectations.